ENTADFI FDA approval date

The FDA approved ENTADFI on 9 Dec 2021.

FDA approval date
9 Dec 2021

Drug identity has not yet been verified against registry records

Also recorded as FINASTERIDE; TADALAFIL

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-12-09DayENTADFIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215423", "applicant_as_listed_by_fda": "BLUE WATER BIOTECH", "brand_names": ["ENTADFI"], "active_ingredients": ["FINASTERIDE", "TADALAFIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20211209", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026